Excellent functional outcome following selective dorsal rhizotomy in a child with spasticity secondary to transverse myelitis

Mazarakis, Nektarios K.; Ughratdar, Ismail; Vloeberghs, Michael

doi:10.1007/s00381-015-2779-2

Cited by 6 publications

(2 citation statements)

References 15 publications

(16 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“… 7 Although CP diagnosis was one of the inclusion criteria of this review, SDR can also be indicated for patients with spasticity resulting from other diagnoses such as multiple sclerosis, Leigh syndrome, 25 stroke, 26 spinal cord injury 24 , and transverse myelitis. 27 …”

Section: Data Synthesismentioning

confidence: 99%

Rizotomia Dorsal Seletiva Na Paralisia Cerebral: Critérios De Indicação E Protocolos De Reabilitação Fisioterapêutica Pós-Operatória

Nicolini‐Panisson

Tedesco²,

Folle³

et al. 2018

Rev. paul. pediatr.

View full text Add to dashboard Cite

Objective: To identify selection criteria for selective dorsal rhizotomy (SDR) in cerebral palsy, to analyze the instruments used for evaluation, and to describe the characteristics of physical therapy in postoperative protocols.Data sources: Integrative review performed in the following databases: SciELO, PEDro, Cochrane Library, and PubMed. The terms in both Portuguese and English for “cerebral palsy”, “selective dorsal rhizotomy”, and “physical therapy” were used in the search. Studies whose samples enrolled individuals with cerebral palsy who had attended physical therapy sessions for selective dorsal rhizotomy according to protocols and describing such protocols’ characteristics were included. Literature reviews were excluded and there was no restriction as to period of publication.Data synthesis: Eighteen papers were selected, most of them being prospective cohort studies with eight-month to ten-year follow-ups. In most studies, the instruments of assessment encompassed the domains of functions, body structure, and activity. The percentage of posterior root sections was close to 50%. Primary indications for SDR included ambulatory spastic diplegia, presence of spasticity that interfered with mobility, good strength of lower limbs and trunk muscles, no musculoskeletal deformities, dystonia, ataxia or athetosis, and good cognitive function. Postoperative physical therapy is part of SDR treatment protocols and should be intensive and specific, being given special emphasis in the first year.Conclusions: The studies underline the importance of appropriate patient selection to obatin success in the SDR. Postoperative physical therapy should be intensive and long-term, and must necessarily include strategies to modify the patient’s former motor pattern.

show abstract

Section: Data Synthesismentioning

confidence: 99%

Rizotomia Dorsal Seletiva Na Paralisia Cerebral: Critérios De Indicação E Protocolos De Reabilitação Fisioterapêutica Pós-Operatória

Nicolini‐Panisson

Tedesco²,

Folle³

et al. 2018

Rev. paul. pediatr.

View full text Add to dashboard Cite

show abstract

“…This treatment reduces the sensory input into spinal-motorneuron pools, reducing their excitability. 18 , 19 Orthopedic surgery (tendon lengthening, soft tissue release, and osteotomies) may be considered in patients with upper and lower limb spasticity after stroke, particularly for equinovarus foot deformity, improving kinetic and kinematic gait parameters. 20 However, further validation of surgical correction of spastic foot following stroke is desirable with higher level of study designs and validated assessment tools.…”

Section: Management Of Poststroke Spasticitymentioning

confidence: 99%

Safety and efficacy of incobotulinumtoxinA as a potential treatment for poststroke spasticity

Santamato¹

2016

NDT

View full text Add to dashboard Cite

Spasticity is a common disabling symptom for several neurological conditions. Botulinum toxin type A injection represents the gold standard treatment for focal spasticity after stroke showing efficacy, reversibility, and low prevalence of complications. In recent years, incobotulinumtoxinA, a new Botulinum toxin type A free of complexing proteins, has been used for treating several movement disorders with safety and efficacy. IncobotulinumtoxinA is currently approved for treating spasticity of the upper limb in stroke survivors, even if several studies described the use also in lower limb muscles. In the present review article, we examine the safety and effectiveness of incobotulinumtoxinA for the treatment of spasticity after stroke.

show abstract

Efficacy of Selective Dorsal Rhizotomy and Intrathecal Baclofen Pump in the Management of Spasticity

Kakodkar

Girgis

Nabhan

et al. 2022

Advances and Technical Standards in Neurosurgery

View full text Add to dashboard Cite

Excellent functional outcome following selective dorsal rhizotomy in a child with spasticity secondary to transverse myelitis

Abstract: This report raises the possibility that the use of SDR could be expanded to include other pathologies. We discuss the case and the relevant literature. Our spasticity service at NUH has to date inserted 300 baclofen pumps and performed 60 SDRs mainly in children with cerebral palsy.

Cited by 6 publications

References 15 publications

Rizotomia Dorsal Seletiva Na Paralisia Cerebral: Critérios De Indicação E Protocolos De Reabilitação Fisioterapêutica Pós-Operatória

Rizotomia Dorsal Seletiva Na Paralisia Cerebral: Critérios De Indicação E Protocolos De Reabilitação Fisioterapêutica Pós-Operatória

Safety and efficacy of incobotulinumtoxinA as a potential treatment for poststroke spasticity

Efficacy of Selective Dorsal Rhizotomy and Intrathecal Baclofen Pump in the Management of Spasticity

Contact Info

Product

Resources

About